2,6-Dibromo-4,4-di-n-octyldithieno[3,2-b:2',3'-d]silole>98.0%(GC)100mg

tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolidine-1-carboxylate, 95.0%, 1g

5-Hydroxyindole-3-acetic Acid>98.0%(HPLC)(T)1g

2-(Trifluoromethoxy)ethylamine hydrochloride, 98.0%, 250mg

1-Bromo-4-(2-iodoethyl)benzene, 95.0%, 5g

3-(4-Ethylphenyl)-1-propene, 97.0%, 25g

(S)-1-(3-FLUORO-PYRIDIN-2-YL)-ETHYLAMINE 2HCL, 97.0%, 1g

4-Amino-3-trifluoromethylbenzylamine, 95.0%, 1g

2-(4-Hydroxy-3-methylphenyl)acetic acid, 95.0%, 10g

1-(4-Aminophenyl)cyclopropanecarbonitrile, 97.0%, 1g

5-Bromo-2,3-difluorobenzene methanol, 98%, 1g

Colonna capillare per GC ROTI®Cap-1, 30 m, 0,25 mm, 0,50 µm, 1 Pezzo(i)

3-((2-Fluoro-4-iodophenyl)amino)isonicotinic acid, 95.0%, 100mg